Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

R-(-)-methamphetamine

Phase 1Small molecule

UUniversity of Wisconsin, Madison

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

MethamphetamineNot yet recruiting

MethamphetaminePhase 1

Not yet recruiting

Timeline

Expected Milestones

Q1 2028

Phase 1Not yet recruiting

Methamphetamine

NCT06746831

Clinical

Trials by Indication[1]

Methamphetamine1 trial

The Low-Down on Methamphetamine Isomers: Prevalence and Pharmacology in Humans

Not yet recruiting·UUniversity of Wisconsin, Madison·Phase 1·NCT06746831·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for R-(-)-methamphetamine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — R-(-)-methamphetamine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for R-(-)-methamphetamine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Wisconsin, Madison company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: UUniversity of Wisconsin, Madison

Related News